APO Research
Talk to an analyst

APO RESEARCH · REPORT

Therapeutic Radioisotopes

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Therapeutic Radioisotopes Market Analysis and Forecast 2026-2032

20 December 2025195 pages

Choose your research edition.

Industry ResearchTherapeutic Radioisotopes Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Therapeutic Radioisotopes Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Therapeutic Radioisotopes Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Therapeutic Radioisotopes Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Therapeutic Radioisotopes Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Therapeutic Radioisotopes market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Therapeutic Radioisotopes is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Therapeutic Radioisotopes is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Therapeutic Radioisotopes is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Therapeutic Radioisotopes is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Therapeutic Radioisotopes include Novartis, Bayer, Q BioMed, Mundipharma, Lantheus, Jubilant Radiopharma, International Isotopes, Dongcheng and Curium Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Therapeutic Radioisotopes, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Therapeutic Radioisotopes, also provides the sales of main regions and countries. Of the upcoming market potential for Therapeutic Radioisotopes, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Therapeutic Radioisotopes sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Therapeutic Radioisotopes market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Therapeutic Radioisotopes sales, projected growth trends, production technology, application and end-user industry.

Therapeutic Radioisotopes Segment by Company

Novartis

Bayer

Q BioMed

Mundipharma

Lantheus

Jubilant Radiopharma

International Isotopes

Dongcheng

Curium Pharmaceuticals

China Isotope & Radiation

Aurobindo Pharma

Therapeutic Radioisotopes Segment by Type

Lutetium-177

Radium-223

Iodine-131

Other

Therapeutic Radioisotopes Segment by Application

Lymphoma

Thyroid

Bone Metastasis

Other

Therapeutic Radioisotopes Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Therapeutic Radioisotopes market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Therapeutic Radioisotopes and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Therapeutic Radioisotopes.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Therapeutic Radioisotopes in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Therapeutic Radioisotopes manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Therapeutic Radioisotopes sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Therapeutic Radioisotopes Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Lutetium-177 Major Manufacturers Table 3. Radium-223 Major Manufacturers Table 4. Iodine-131 Major Manufacturers Table 5. Other Major Manufacturers Table 6. Global Therapeutic Radioisotopes Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Lymphoma Major Manufacturers Table 8. Thyroid Major Manufacturers Table 9. Bone Metastasis Major Manufacturers Table 10. Other Major Manufacturers Table 11. Therapeutic Radioisotopes Industry Trends Table 12. Therapeutic Radioisotopes Industry Drivers Table 13. Therapeutic Radioisotopes Industry Opportunities and Challenges Table 14. Therapeutic Radioisotopes Industry Restraints Table 15. Global Therapeutic Radioisotopes Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Therapeutic Radioisotopes Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Therapeutic Radioisotopes Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Therapeutic Radioisotopes Revenue Market Share by Region (2021-2026) Table 19. Global Therapeutic Radioisotopes Revenue Market Share by Region (2027-2032) Table 20. Global Therapeutic Radioisotopes Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 21. Global Therapeutic Radioisotopes Sales by Region (2021-2026) & (k units) Table 22. Global Therapeutic Radioisotopes Sales by Region (2027-2032) & (k units) Table 23. Global Therapeutic Radioisotopes Sales Market Share by Region (2021-2026) Table 24. Global Therapeutic Radioisotopes Sales Market Share by Region (2027-2032) Table 25. Global Therapeutic Radioisotopes Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Therapeutic Radioisotopes Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Therapeutic Radioisotopes Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Therapeutic Radioisotopes Sales Market Share by Manufacturers (2021-2026) Table 29. Global Therapeutic Radioisotopes Sales Price (US$/unit) of Manufacturers (2021-2026) Table 30. Global Therapeutic Radioisotopes Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Therapeutic Radioisotopes Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Therapeutic Radioisotopes Manufacturers, Product Type & Application Table 33. Global Therapeutic Radioisotopes Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Therapeutic Radioisotopes by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Therapeutic Radioisotopes Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Therapeutic Radioisotopes Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Therapeutic Radioisotopes Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Therapeutic Radioisotopes Revenue Market Share by Type (2021-2026) Table 40. Global Therapeutic Radioisotopes Revenue Market Share by Type (2027-2032) Table 41. Global Therapeutic Radioisotopes Sales by Type 2021 VS 2025 VS 2032 (k units) Table 42. Global Therapeutic Radioisotopes Sales by Type (2021-2026) & (k units) Table 43. Global Therapeutic Radioisotopes Sales by Type (2027-2032) & (k units) Table 44. Global Therapeutic Radioisotopes Sales Market Share by Type (2021-2026) Table 45. Global Therapeutic Radioisotopes Sales Market Share by Type (2027-2032) Table 46. Global Therapeutic Radioisotopes Price by Type (2021-2026) & (US$/unit) Table 47. Global Therapeutic Radioisotopes Price by Type (2027-2032) & (US$/unit) Table 48. Global Therapeutic Radioisotopes Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Therapeutic Radioisotopes Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Therapeutic Radioisotopes Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Therapeutic Radioisotopes Revenue Market Share by Application (2021-2026) Table 52. Global Therapeutic Radioisotopes Revenue Market Share by Application (2027-2032) Table 53. Global Therapeutic Radioisotopes Sales by Application 2021 VS 2025 VS 2032 (k units) Table 54. Global Therapeutic Radioisotopes Sales by Application (2021-2026) & (k units) Table 55. Global Therapeutic Radioisotopes Sales by Application (2027-2032) & (k units) Table 56. Global Therapeutic Radioisotopes Sales Market Share by Application (2021-2026) Table 57. Global Therapeutic Radioisotopes Sales Market Share by Application (2027-2032) Table 58. Global Therapeutic Radioisotopes Price by Application (2021-2026) & (US$/unit) Table 59. Global Therapeutic Radioisotopes Price by Application (2027-2032) & (US$/unit) Table 60. Novartis Company Information Table 61. Novartis Business Overview Table 62. Novartis Therapeutic Radioisotopes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 63. Novartis Therapeutic Radioisotopes Product Portfolio Table 64. Novartis Recent Development Table 65. Bayer Company Information Table 66. Bayer Business Overview Table 67. Bayer Therapeutic Radioisotopes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 68. Bayer Therapeutic Radioisotopes Product Portfolio Table 69. Bayer Recent Development Table 70. Q BioMed Company Information Table 71. Q BioMed Business Overview Table 72. Q BioMed Therapeutic Radioisotopes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 73. Q BioMed Therapeutic Radioisotopes Product Portfolio Table 74. Q BioMed Recent Development Table 75. Mundipharma Company Information Table 76. Mundipharma Business Overview Table 77. Mundipharma Therapeutic Radioisotopes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 78. Mundipharma Therapeutic Radioisotopes Product Portfolio Table 79. Mundipharma Recent Development Table 80. Lantheus Company Information Table 81. Lantheus Business Overview Table 82. Lantheus Therapeutic Radioisotopes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 83. Lantheus Therapeutic Radioisotopes Product Portfolio Table 84. Lantheus Recent Development Table 85. Jubilant Radiopharma Company Information Table 86. Jubilant Radiopharma Business Overview Table 87. Jubilant Radiopharma Therapeutic Radioisotopes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. Jubilant Radiopharma Therapeutic Radioisotopes Product Portfolio Table 89. Jubilant Radiopharma Recent Development Table 90. International Isotopes Company Information Table 91. International Isotopes Business Overview Table 92. International Isotopes Therapeutic Radioisotopes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. International Isotopes Therapeutic Radioisotopes Product Portfolio Table 94. International Isotopes Recent Development Table 95. Dongcheng Company Information Table 96. Dongcheng Business Overview Table 97. Dongcheng Therapeutic Radioisotopes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. Dongcheng Therapeutic Radioisotopes Product Portfolio Table 99. Dongcheng Recent Development Table 100. Curium Pharmaceuticals Company Information Table 101. Curium Pharmaceuticals Business Overview Table 102. Curium Pharmaceuticals Therapeutic Radioisotopes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 103. Curium Pharmaceuticals Therapeutic Radioisotopes Product Portfolio Table 104. Curium Pharmaceuticals Recent Development Table 105. China Isotope & Radiation Company Information Table 106. China Isotope & Radiation Business Overview Table 107. China Isotope & Radiation Therapeutic Radioisotopes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 108. China Isotope & Radiation Therapeutic Radioisotopes Product Portfolio Table 109. China Isotope & Radiation Recent Development Table 110. Aurobindo Pharma Company Information Table 111. Aurobindo Pharma Business Overview Table 112. Aurobindo Pharma Therapeutic Radioisotopes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 113. Aurobindo Pharma Therapeutic Radioisotopes Product Portfolio Table 114. Aurobindo Pharma Recent Development Table 115. North America Therapeutic Radioisotopes Revenue by Type (2021-2026) & (US$ Million) Table 116. North America Therapeutic Radioisotopes Revenue by Type (2027-2032) & (US$ Million) Table 117. North America Therapeutic Radioisotopes Sales by Type (2021-2026) & (k units) Table 118. North America Therapeutic Radioisotopes Sales by Type (2027-2032) & (k units) Table 119. North America Therapeutic Radioisotopes Sales Price by Type (2021-2026) & (US$/unit) Table 120. North America Therapeutic Radioisotopes Sales Price by Type (2027-2032) & (US$/unit) Table 121. North America Therapeutic Radioisotopes Revenue by Application (2021-2026) & (US$ Million) Table 122. North America Therapeutic Radioisotopes Revenue by Application (2027-2032) & (US$ Million) Table 123. North America Therapeutic Radioisotopes Sales by Application (2021-2026) & (k units) Table 124. North America Therapeutic Radioisotopes Sales by Application (2027-2032) & (k units) Table 125. North America Therapeutic Radioisotopes Sales Price by Application (2021-2026) & (US$/unit) Table 126. North America Therapeutic Radioisotopes Sales Price by Application (2027-2032) & (US$/unit) Table 127. North America Therapeutic Radioisotopes Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. North America Therapeutic Radioisotopes Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 129. North America Therapeutic Radioisotopes Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 130. North America Therapeutic Radioisotopes Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 131. North America Therapeutic Radioisotopes Sales by Country (2021-2026) & (k units) Table 132. North America Therapeutic Radioisotopes Sales by Country (2027-2032) & (k units) Table 133. North America Therapeutic Radioisotopes Sales Price by Country (2021-2026) & (US$/unit) Table 134. North America Therapeutic Radioisotopes Sales Price by Country (2027-2032) & (US$/unit) Table 135. United States Therapeutic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 136. Canada Therapeutic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 137. Mexico Therapeutic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 138. Europe Therapeutic Radioisotopes Revenue by Type (2021-2026) & (US$ Million) Table 139. Europe Therapeutic Radioisotopes Revenue by Type (2027-2032) & (US$ Million) Table 140. Europe Therapeutic Radioisotopes Sales by Type (2021-2026) & (k units) Table 141. Europe Therapeutic Radioisotopes Sales by Type (2027-2032) & (k units) Table 142. Europe Therapeutic Radioisotopes Sales Price by Type (2021-2026) & (US$/unit) Table 143. Europe Therapeutic Radioisotopes Sales Price by Type (2027-2032) & (US$/unit) Table 144. Europe Therapeutic Radioisotopes Revenue by Application (2021-2026) & (US$ Million) Table 145. Europe Therapeutic Radioisotopes Revenue by Application (2027-2032) & (US$ Million) Table 146. Europe Therapeutic Radioisotopes Sales by Application (2021-2026) & (k units) Table 147. Europe Therapeutic Radioisotopes Sales by Application (2027-2032) & (k units) Table 148. Europe Therapeutic Radioisotopes Sales Price by Application (2021-2026) & (US$/unit) Table 149. Europe Therapeutic Radioisotopes Sales Price by Application (2027-2032) & (US$/unit) Table 150. Europe Therapeutic Radioisotopes Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 151. Europe Therapeutic Radioisotopes Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 152. Europe Therapeutic Radioisotopes Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 153. Europe Therapeutic Radioisotopes Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 154. Europe Therapeutic Radioisotopes Sales by Country (2021-2026) & (k units) Table 155. Europe Therapeutic Radioisotopes Sales by Country (2027-2032) & (k units) Table 156. Europe Therapeutic Radioisotopes Sales Price by Country (2021-2026) & (US$/unit) Table 157. Europe Therapeutic Radioisotopes Sales Price by Country (2027-2032) & (US$/unit) Table 158. Germany Therapeutic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 159. France Therapeutic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 160. U.K. Therapeutic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 161. Italy Therapeutic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 162. Russia Therapeutic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 163. Spain Therapeutic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 164. Netherlands Therapeutic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 165. Switzerland Therapeutic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 166. Sweden Therapeutic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 167. Poland Therapeutic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 168. China Therapeutic Radioisotopes Revenue by Type (2021-2026) & (US$ Million) Table 169. China Therapeutic Radioisotopes Revenue by Type (2027-2032) & (US$ Million) Table 170. China Therapeutic Radioisotopes Sales by Type (2021-2026) & (k units) Table 171. China Therapeutic Radioisotopes Sales by Type (2027-2032) & (k units) Table 172. China Therapeutic Radioisotopes Sales Price by Type (2021-2026) & (US$/unit) Table 173. China Therapeutic Radioisotopes Sales Price by Type (2027-2032) & (US$/unit) Table 174. China Therapeutic Radioisotopes Revenue by Application (2021-2026) & (US$ Million) Table 175. China Therapeutic Radioisotopes Revenue by Application (2027-2032) & (US$ Million) Table 176. China Therapeutic Radioisotopes Sales by Application (2021-2026) & (k units) Table 177. China Therapeutic Radioisotopes Sales by Application (2027-2032) & (k units) Table 178. China Therapeutic Radioisotopes Sales Price by Application (2021-2026) & (US$/unit) Table 179. China Therapeutic Radioisotopes Sales Price by Application (2027-2032) & (US$/unit) Table 180. Asia Therapeutic Radioisotopes Revenue by Type (2021-2026) & (US$ Million) Table 181. Asia Therapeutic Radioisotopes Revenue by Type (2027-2032) & (US$ Million) Table 182. Asia Therapeutic Radioisotopes Sales by Type (2021-2026) & (k units) Table 183. Asia Therapeutic Radioisotopes Sales by Type (2027-2032) & (k units) Table 184. Asia Therapeutic Radioisotopes Sales Price by Type (2021-2026) & (US$/unit) Table 185. Asia Therapeutic Radioisotopes Sales Price by Type (2027-2032) & (US$/unit) Table 186. Asia Therapeutic Radioisotopes Revenue by Application (2021-2026) & (US$ Million) Table 187. Asia Therapeutic Radioisotopes Revenue by Application (2027-2032) & (US$ Million) Table 188. Asia Therapeutic Radioisotopes Sales by Application (2021-2026) & (k units) Table 189. Asia Therapeutic Radioisotopes Sales by Application (2027-2032) & (k units) Table 190. Asia Therapeutic Radioisotopes Sales Price by Application (2021-2026) & (US$/unit) Table 191. Asia Therapeutic Radioisotopes Sales Price by Application (2027-2032) & (US$/unit) Table 192. Asia Therapeutic Radioisotopes Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 193. Asia Therapeutic Radioisotopes Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 194. Asia Therapeutic Radioisotopes Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 195. Asia Therapeutic Radioisotopes Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 196. Asia Therapeutic Radioisotopes Sales by Country (2021-2026) & (k units) Table 197. Asia Therapeutic Radioisotopes Sales by Country (2027-2032) & (k units) Table 198. Asia Therapeutic Radioisotopes Sales Price by Country (2021-2026) & (US$/unit) Table 199. Asia Therapeutic Radioisotopes Sales Price by Country (2027-2032) & (US$/unit) Table 200. Japan Therapeutic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 201. South Korea Therapeutic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 202. India Therapeutic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 203. Australia Therapeutic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 204. Taiwan Therapeutic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 205. Southeast Asia Therapeutic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 206. SAMEA Therapeutic Radioisotopes Revenue by Type (2021-2026) & (US$ Million) Table 207. SAMEA Therapeutic Radioisotopes Revenue by Type (2027-2032) & (US$ Million) Table 208. SAMEA Therapeutic Radioisotopes Sales by Type (2021-2026) & (k units) Table 209. SAMEA Therapeutic Radioisotopes Sales by Type (2027-2032) & (k units) Table 210. SAMEA Therapeutic Radioisotopes Sales Price by Type (2021-2026) & (US$/unit) Table 211. SAMEA Therapeutic Radioisotopes Sales Price by Type (2027-2032) & (US$/unit) Table 212. SAMEA Therapeutic Radioisotopes Revenue by Application (2021-2026) & (US$ Million) Table 213. SAMEA Therapeutic Radioisotopes Revenue by Application (2027-2032) & (US$ Million) Table 214. SAMEA Therapeutic Radioisotopes Sales by Application (2021-2026) & (k units) Table 215. SAMEA Therapeutic Radioisotopes Sales by Application (2027-2032) & (k units) Table 216. SAMEA Therapeutic Radioisotopes Sales Price by Application (2021-2026) & (US$/unit) Table 217. SAMEA Therapeutic Radioisotopes Sales Price by Application (2027-2032) & (US$/unit) Table 218. SAMEA Therapeutic Radioisotopes Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 219. SAMEA Therapeutic Radioisotopes Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 220. SAMEA Therapeutic Radioisotopes Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 221. SAMEA Therapeutic Radioisotopes Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 222. SAMEA Therapeutic Radioisotopes Sales by Country (2021-2026) & (k units) Table 223. SAMEA Therapeutic Radioisotopes Sales by Country (2027-2032) & (k units) Table 224. SAMEA Therapeutic Radioisotopes Sales Price by Country (2021-2026) & (US$/unit) Table 225. SAMEA Therapeutic Radioisotopes Sales Price by Country (2027-2032) & (US$/unit) Table 226. Brazil Therapeutic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 227. Argentina Therapeutic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 228. Chile Therapeutic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 229. Colombia Therapeutic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 230. Peru Therapeutic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 231. Saudi Arabia Therapeutic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 232. Israel Therapeutic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 233. UAE Therapeutic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 234. Turkey Therapeutic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 235. Iran Therapeutic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 236. Egypt Therapeutic Radioisotopes Revenue (2021-2032) & (US$ Million) Table 237. Key Raw Materials Table 238. Raw Materials Key Suppliers Table 239. Therapeutic Radioisotopes Distributors List Table 240. Therapeutic Radioisotopes Customers List Table 241. Research Programs/Design for This Report Table 242. Authors List of This Report Table 243. Secondary Sources Table 244. Primary Sources List of Figures Figure 1. Therapeutic Radioisotopes Image Figure 2. Global Therapeutic Radioisotopes Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Therapeutic Radioisotopes Market Size Share 2021 VS 2025 VS 2032 Figure 4. Lutetium-177 Image Figure 5. Radium-223 Image Figure 6. Iodine-131 Image Figure 7. Other Image Figure 8. Global Therapeutic Radioisotopes Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Therapeutic Radioisotopes Market Size Share 2021 VS 2025 VS 2032 Figure 10. Lymphoma Image Figure 11. Thyroid Image Figure 12. Bone Metastasis Image Figure 13. Other Image Figure 14. Global Therapeutic Radioisotopes Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Therapeutic Radioisotopes Revenue (2021-2032) & (US$ Million) Figure 16. Global Therapeutic Radioisotopes Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Therapeutic Radioisotopes Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Therapeutic Radioisotopes Revenue Market Share by Region (2021-2032) Figure 19. Global Therapeutic Radioisotopes Sales (2021-2032) & (k units) Figure 20. Global Therapeutic Radioisotopes Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 21. Global Therapeutic Radioisotopes Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Therapeutic Radioisotopes Sales YoY (2021-2032) & (k units) Figure 23. Europe Therapeutic Radioisotopes Sales YoY (2021-2032) & (k units) Figure 24. China Therapeutic Radioisotopes Sales YoY (2021-2032) & (k units) Figure 25. Asia (Excluding China) Therapeutic Radioisotopes Sales YoY (2021-2032) & (k units) Figure 26. South America, Middle East and Africa Therapeutic Radioisotopes Sales YoY (2021-2032) & (k units) Figure 27. Global Therapeutic Radioisotopes Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Therapeutic Radioisotopes Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Therapeutic Radioisotopes Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Therapeutic Radioisotopes Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Therapeutic Radioisotopes Revenue Market Share by Type (2021-2032) Figure 33. Global Therapeutic Radioisotopes Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 34. Global Therapeutic Radioisotopes Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Therapeutic Radioisotopes Sales Market Share by Type (2021-2032) Figure 36. Global Therapeutic Radioisotopes Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Therapeutic Radioisotopes Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Therapeutic Radioisotopes Revenue Market Share by Application (2021-2032) Figure 39. Global Therapeutic Radioisotopes Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 40. Global Therapeutic Radioisotopes Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Therapeutic Radioisotopes Sales Market Share by Application (2021-2032) Figure 42. North America Therapeutic Radioisotopes Revenue Share by Type (2021-2032) Figure 43. North America Therapeutic Radioisotopes Sales Share by Type (2021-2032) Figure 44. North America Therapeutic Radioisotopes Revenue Share by Application (2021-2032) Figure 45. North America Therapeutic Radioisotopes Sales Share by Application (2021-2032) Figure 46. North America Therapeutic Radioisotopes Revenue Share by Country (2021-2032) Figure 47. North America Therapeutic Radioisotopes Sales Share by Country (2021-2032) Figure 48. Europe Therapeutic Radioisotopes Revenue Share by Type (2021-2032) Figure 49. Europe Therapeutic Radioisotopes Sales Share by Type (2021-2032) Figure 50. Europe Therapeutic Radioisotopes Revenue Share by Application (2021-2032) Figure 51. Europe Therapeutic Radioisotopes Sales Share by Application (2021-2032) Figure 52. Europe Therapeutic Radioisotopes Revenue Share by Country (2021-2032) Figure 53. Europe Therapeutic Radioisotopes Sales Share by Country (2021-2032) Figure 54. China Therapeutic Radioisotopes Revenue Share by Type (2021-2032) Figure 55. China Therapeutic Radioisotopes Sales Share by Type (2021-2032) Figure 56. China Therapeutic Radioisotopes Revenue Share by Application (2021-2032) Figure 57. China Therapeutic Radioisotopes Sales Share by Application (2021-2032) Figure 58. Asia Therapeutic Radioisotopes Revenue Share by Type (2021-2032) Figure 59. Asia Therapeutic Radioisotopes Sales Share by Type (2021-2032) Figure 60. Asia Therapeutic Radioisotopes Revenue Share by Application (2021-2032) Figure 61. Asia Therapeutic Radioisotopes Sales Share by Application (2021-2032) Figure 62. Asia Therapeutic Radioisotopes Revenue Share by Country (2021-2032) Figure 63. Asia Therapeutic Radioisotopes Sales Share by Country (2021-2032) Figure 64. SAMEA Therapeutic Radioisotopes Revenue Share by Type (2021-2032) Figure 65. SAMEA Therapeutic Radioisotopes Sales Share by Type (2021-2032) Figure 66. SAMEA Therapeutic Radioisotopes Revenue Share by Application (2021-2032) Figure 67. SAMEA Therapeutic Radioisotopes Sales Share by Application (2021-2032) Figure 68. SAMEA Therapeutic Radioisotopes Revenue Share by Country (2021-2032) Figure 69. SAMEA Therapeutic Radioisotopes Sales Share by Country (2021-2032) Figure 70. Therapeutic Radioisotopes Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Therapeutic Radioisotopes Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Lutetium-177
  • Radium-223
  • Iodine-131
  • Other
Applications
  • Lymphoma
  • Thyroid
  • Bone Metastasis
  • Other
Companies covered
  • Novartis
  • Bayer
  • Q BioMed
  • Mundipharma
  • Lantheus
  • Jubilant Radiopharma
  • International Isotopes
  • Dongcheng
  • Curium Pharmaceuticals
  • China Isotope & Radiation
  • Aurobindo Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Therapeutic Radioisotopes Market by Type
  3. 1.2.1 Global Therapeutic Radioisotopes Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Lutetium-177
  5. 1.2.3 Radium-223
  6. 1.2.4 Iodine-131
  7. 1.2.5 Other
  8. 1.3 Therapeutic Radioisotopes Market by Application
  9. 1.3.1 Global Therapeutic Radioisotopes Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Lymphoma
  11. 1.3.3 Thyroid
  12. 1.3.4 Bone Metastasis
  13. 1.3.5 Other
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Therapeutic Radioisotopes Market Dynamics
  1. 2.1 Therapeutic Radioisotopes Industry Trends
  2. 2.2 Therapeutic Radioisotopes Industry Drivers
  3. 2.3 Therapeutic Radioisotopes Industry Opportunities and Challenges
  4. 2.4 Therapeutic Radioisotopes Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Therapeutic Radioisotopes Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Therapeutic Radioisotopes Revenue by Region
  3. 3.2.1 Global Therapeutic Radioisotopes Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Therapeutic Radioisotopes Revenue by Region (2021-2026)
  5. 3.2.3 Global Therapeutic Radioisotopes Revenue by Region (2027-2032)
  6. 3.2.4 Global Therapeutic Radioisotopes Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Therapeutic Radioisotopes Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Therapeutic Radioisotopes Sales by Region
  9. 3.4.1 Global Therapeutic Radioisotopes Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Therapeutic Radioisotopes Sales by Region (2021-2026)
  11. 3.4.3 Global Therapeutic Radioisotopes Sales by Region (2027-2032)
  12. 3.4.4 Global Therapeutic Radioisotopes Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Therapeutic Radioisotopes Revenue by Manufacturers
  2. 4.1.1 Global Therapeutic Radioisotopes Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Therapeutic Radioisotopes Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Therapeutic Radioisotopes Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Therapeutic Radioisotopes Sales by Manufacturers
  6. 4.2.1 Global Therapeutic Radioisotopes Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Therapeutic Radioisotopes Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Therapeutic Radioisotopes Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Therapeutic Radioisotopes Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Therapeutic Radioisotopes Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Therapeutic Radioisotopes Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Therapeutic Radioisotopes Manufacturers, Product Type & Application
  13. 4.7 Global Therapeutic Radioisotopes Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Therapeutic Radioisotopes Market CR5 and HHI
  16. 4.8.2 2025 Therapeutic Radioisotopes Tier 1, Tier 2, and Tier 3
5 Therapeutic Radioisotopes Market by Type
  1. 5.1 Global Therapeutic Radioisotopes Revenue by Type
  2. 5.1.1 Global Therapeutic Radioisotopes Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Therapeutic Radioisotopes Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Therapeutic Radioisotopes Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Therapeutic Radioisotopes Sales by Type
  6. 5.2.1 Global Therapeutic Radioisotopes Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Therapeutic Radioisotopes Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Therapeutic Radioisotopes Sales Market Share by Type (2021-2032)
  9. 5.3 Global Therapeutic Radioisotopes Price by Type
6 Therapeutic Radioisotopes Market by Application
  1. 6.1 Global Therapeutic Radioisotopes Revenue by Application
  2. 6.1.1 Global Therapeutic Radioisotopes Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Therapeutic Radioisotopes Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Therapeutic Radioisotopes Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Therapeutic Radioisotopes Sales by Application
  6. 6.2.1 Global Therapeutic Radioisotopes Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Therapeutic Radioisotopes Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Therapeutic Radioisotopes Sales Market Share by Application (2021-2032)
  9. 6.3 Global Therapeutic Radioisotopes Price by Application
7 Company Profiles
  1. 7.1 Novartis
  2. 7.1.1 Novartis Company Information
  3. 7.1.2 Novartis Business Overview
  4. 7.1.3 Novartis Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Novartis Therapeutic Radioisotopes Product Portfolio
  6. 7.1.5 Novartis Recent Developments
  7. 7.2 Bayer
  8. 7.2.1 Bayer Company Information
  9. 7.2.2 Bayer Business Overview
  10. 7.2.3 Bayer Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Bayer Therapeutic Radioisotopes Product Portfolio
  12. 7.2.5 Bayer Recent Developments
  13. 7.3 Q BioMed
  14. 7.3.1 Q BioMed Company Information
  15. 7.3.2 Q BioMed Business Overview
  16. 7.3.3 Q BioMed Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Q BioMed Therapeutic Radioisotopes Product Portfolio
  18. 7.3.5 Q BioMed Recent Developments
  19. 7.4 Mundipharma
  20. 7.4.1 Mundipharma Company Information
  21. 7.4.2 Mundipharma Business Overview
  22. 7.4.3 Mundipharma Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Mundipharma Therapeutic Radioisotopes Product Portfolio
  24. 7.4.5 Mundipharma Recent Developments
  25. 7.5 Lantheus
  26. 7.5.1 Lantheus Company Information
  27. 7.5.2 Lantheus Business Overview
  28. 7.5.3 Lantheus Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Lantheus Therapeutic Radioisotopes Product Portfolio
  30. 7.5.5 Lantheus Recent Developments
  31. 7.6 Jubilant Radiopharma
  32. 7.6.1 Jubilant Radiopharma Company Information
  33. 7.6.2 Jubilant Radiopharma Business Overview
  34. 7.6.3 Jubilant Radiopharma Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Jubilant Radiopharma Therapeutic Radioisotopes Product Portfolio
  36. 7.6.5 Jubilant Radiopharma Recent Developments
  37. 7.7 International Isotopes
  38. 7.7.1 International Isotopes Company Information
  39. 7.7.2 International Isotopes Business Overview
  40. 7.7.3 International Isotopes Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 International Isotopes Therapeutic Radioisotopes Product Portfolio
  42. 7.7.5 International Isotopes Recent Developments
  43. 7.8 Dongcheng
  44. 7.8.1 Dongcheng Company Information
  45. 7.8.2 Dongcheng Business Overview
  46. 7.8.3 Dongcheng Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Dongcheng Therapeutic Radioisotopes Product Portfolio
  48. 7.8.5 Dongcheng Recent Developments
  49. 7.9 Curium Pharmaceuticals
  50. 7.9.1 Curium Pharmaceuticals Company Information
  51. 7.9.2 Curium Pharmaceuticals Business Overview
  52. 7.9.3 Curium Pharmaceuticals Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Curium Pharmaceuticals Therapeutic Radioisotopes Product Portfolio
  54. 7.9.5 Curium Pharmaceuticals Recent Developments
  55. 7.10 China Isotope & Radiation
  56. 7.10.1 China Isotope & Radiation Company Information
  57. 7.10.2 China Isotope & Radiation Business Overview
  58. 7.10.3 China Isotope & Radiation Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 China Isotope & Radiation Therapeutic Radioisotopes Product Portfolio
  60. 7.10.5 China Isotope & Radiation Recent Developments
  61. 7.11 Aurobindo Pharma
  62. 7.11.1 Aurobindo Pharma Company Information
  63. 7.11.2 Aurobindo Pharma Business Overview
  64. 7.11.3 Aurobindo Pharma Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Aurobindo Pharma Therapeutic Radioisotopes Product Portfolio
  66. 7.11.5 Aurobindo Pharma Recent Developments
8 North America
  1. 8.1 North America Therapeutic Radioisotopes Market Size by Type
  2. 8.1.1 North America Therapeutic Radioisotopes Revenue by Type (2021-2032)
  3. 8.1.2 North America Therapeutic Radioisotopes Sales by Type (2021-2032)
  4. 8.1.3 North America Therapeutic Radioisotopes Price by Type (2021-2032)
  5. 8.2 North America Therapeutic Radioisotopes Market Size by Application
  6. 8.2.1 North America Therapeutic Radioisotopes Revenue by Application (2021-2032)
  7. 8.2.2 North America Therapeutic Radioisotopes Sales by Application (2021-2032)
  8. 8.2.3 North America Therapeutic Radioisotopes Price by Application (2021-2032)
  9. 8.3 North America Therapeutic Radioisotopes Market Size by Country
  10. 8.3.1 North America Therapeutic Radioisotopes Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Therapeutic Radioisotopes Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Therapeutic Radioisotopes Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Therapeutic Radioisotopes Market Size by Type
  2. 9.1.1 Europe Therapeutic Radioisotopes Revenue by Type (2021-2032)
  3. 9.1.2 Europe Therapeutic Radioisotopes Sales by Type (2021-2032)
  4. 9.1.3 Europe Therapeutic Radioisotopes Price by Type (2021-2032)
  5. 9.2 Europe Therapeutic Radioisotopes Market Size by Application
  6. 9.2.1 Europe Therapeutic Radioisotopes Revenue by Application (2021-2032)
  7. 9.2.2 Europe Therapeutic Radioisotopes Sales by Application (2021-2032)
  8. 9.2.3 Europe Therapeutic Radioisotopes Price by Application (2021-2032)
  9. 9.3 Europe Therapeutic Radioisotopes Market Size by Country
  10. 9.3.1 Europe Therapeutic Radioisotopes Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Therapeutic Radioisotopes Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Therapeutic Radioisotopes Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Therapeutic Radioisotopes Market Size by Type
  2. 10.1.1 China Therapeutic Radioisotopes Revenue by Type (2021-2032)
  3. 10.1.2 China Therapeutic Radioisotopes Sales by Type (2021-2032)
  4. 10.1.3 China Therapeutic Radioisotopes Price by Type (2021-2032)
  5. 10.2 China Therapeutic Radioisotopes Market Size by Application
  6. 10.2.1 China Therapeutic Radioisotopes Revenue by Application (2021-2032)
  7. 10.2.2 China Therapeutic Radioisotopes Sales by Application (2021-2032)
  8. 10.2.3 China Therapeutic Radioisotopes Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Therapeutic Radioisotopes Market Size by Type
  2. 11.1.1 Asia Therapeutic Radioisotopes Revenue by Type (2021-2032)
  3. 11.1.2 Asia Therapeutic Radioisotopes Sales by Type (2021-2032)
  4. 11.1.3 Asia Therapeutic Radioisotopes Price by Type (2021-2032)
  5. 11.2 Asia Therapeutic Radioisotopes Market Size by Application
  6. 11.2.1 Asia Therapeutic Radioisotopes Revenue by Application (2021-2032)
  7. 11.2.2 Asia Therapeutic Radioisotopes Sales by Application (2021-2032)
  8. 11.2.3 Asia Therapeutic Radioisotopes Price by Application (2021-2032)
  9. 11.3 Asia Therapeutic Radioisotopes Market Size by Country
  10. 11.3.1 Asia Therapeutic Radioisotopes Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Therapeutic Radioisotopes Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Therapeutic Radioisotopes Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Therapeutic Radioisotopes Market Size by Type
  2. 12.1.1 SAMEA Therapeutic Radioisotopes Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Therapeutic Radioisotopes Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Therapeutic Radioisotopes Price by Type (2021-2032)
  5. 12.2 SAMEA Therapeutic Radioisotopes Market Size by Application
  6. 12.2.1 SAMEA Therapeutic Radioisotopes Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Therapeutic Radioisotopes Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Therapeutic Radioisotopes Price by Application (2021-2032)
  9. 12.3 SAMEA Therapeutic Radioisotopes Market Size by Country
  10. 12.3.1 SAMEA Therapeutic Radioisotopes Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Therapeutic Radioisotopes Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Therapeutic Radioisotopes Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Therapeutic Radioisotopes Value Chain Analysis
  2. 13.1.1 Therapeutic Radioisotopes Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Therapeutic Radioisotopes Production Mode & Process
  6. 13.2 Therapeutic Radioisotopes Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Therapeutic Radioisotopes Distributors
  9. 13.2.3 Therapeutic Radioisotopes Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst